Brighter has been granted a patent for AI-powered monitoring of medical devices.
Brighter has been granted a patent for computer driven monitoring of the health of portable medical devices. The patent ensures rights to a system that enables AI-powered monitoring of the functionality of mobile medical equipment with injection tool, such as the company's diabetes management device Actiste, to decide whether the device needs to be repaired, serviced or replaced.
“For patient-safety reasons, it is of great importance that injection devices work in a correct and reliable manner. At the same time such devices, which usually are carried by the users at all times, are likely to be exposed to a number of external stresses such as temperature changes, humidity or chock if the user drops the device, which can cause damage. Furthermore, daily use causes general wear. It’s important for us to be able to monitor this remotely, optimally through advanced AI technology, so that we quickly can identify a potential problem and repair or replace the product in case the user haven’t noticed and reported it,” says Truls Sjöstedt, Brighter’s CEO and founder.
For further information, please contact:
Rasmus Karlgren, Media & Communications Manager
Phone: +4672 999 38 64
Email: rasmus.karlgren@brighter.se
About Actiste.
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.
Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. https://actiste.com/
About Brighter AB.
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their relatives, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.